dc.date.accessioned |
2020-10-21T06:45:21Z |
|
dc.date.available |
2020-10-21T06:45:21Z |
|
dc.date.issued |
2019 |
|
dc.date.issued |
2019/02/12 |
|
dc.identifier.citation |
Demir M, Aladag M, Erol C.J Viral Hepat. 2019 Jun;26(6):666-674. doi: 10.1111/jvh.13075. Epub 2019 Mar 8. |
|
dc.identifier.uri |
http://doi.org/10.1111/jvh.13075 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/71572 |
|
dc.description |
PMID = 30740820 |
|
dc.relation.isversionof |
10.1111/jvh.13075 |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.title |
Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort |
|
dc.type |
article |
|
dc.relation.journal |
J Viral Hepat |
|
dc.identifier.doi |
10.1111/jvh.13075 |
|
dc.contributor.author |
Idilman R |
|
dc.contributor.author |
Demir M |
|
dc.contributor.author |
Aladag M |
|
dc.contributor.author |
Erol C |
|
dc.contributor.author |
Cavus B |
|
dc.contributor.author |
Iliaz R |
|
dc.contributor.author |
Koklu H |
|
dc.contributor.author |
Cakaloglu Y |
|
dc.contributor.author |
Sahin M |
|
dc.contributor.author |
Ersoz G |
|
dc.contributor.author |
Koksal İ |
|
dc.contributor.author |
Karasu Z |
|
dc.contributor.author |
Ozgenel M |
|
dc.contributor.author |
Turan İ |
|
dc.contributor.author |
Gunduz F |
|
dc.contributor.author |
Ataseven H |
|
dc.contributor.author |
Akdogan M |
|
dc.contributor.author |
Kiyici M |
|
dc.contributor.author |
Koksal AS |
|
dc.contributor.author |
Akhan S |
|
dc.contributor.author |
Gunsar F |
|
dc.contributor.author |
Tabak F |
|
dc.contributor.author |
Kaymakoglu S |
|
dc.contributor.author |
Akarca US; Early Access Program (EAP) Study Groupa. |
|
dc.relation.publicationcategory |
Makale - Uluslararası Hakemli Dergi |
|